Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 19.17
+0.55 (2.95%)
At close: Mar 27, 2026
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 11.41 billion as of March 27, 2026. Its market cap has increased by 10.24% in one year.
Market Cap
11.41B
Enterprise Value
9.08B
Revenue
1.20B
Ranking
n/a
PE Ratio
62.36
Stock Price
19.17
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 11.41B, a decrease of -59.44%. That is a compound annual growth rate of -19.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 11.41B | 2.90% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| Chengdu Olymvax Biopharmaceuticals | 12.07B |
| Beijing Hotgen Biotech | 11.74B |
| Chengdu Easton Biopharmaceuticals | 11.57B |
| InventisBio | 11.56B |